Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 801-277-8 | CAS number: 507448-65-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 999
- Report date:
- 1999
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
Test material
- Reference substance name:
- ethyl (2Z)-4,4,4-trifluoro-3-(methylamino)but-2-enoate
- EC Number:
- 801-277-8
- Cas Number:
- 507448-65-9
- Molecular formula:
- C7H10F3NO2
- IUPAC Name:
- ethyl (2Z)-4,4,4-trifluoro-3-(methylamino)but-2-enoate
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Himalayan
- Sex:
- male/female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: BRL Biological Research Laboratories, Wölferstrasse 4, 4414 Füllinsdorf / Switzerland
- Age at study initiation: Young adult (approximately 1 - 3 months)
- Weight at study initiation: 336 - 433 g
- Housing: Individual
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3 °C
- Humidity (%): 50 ± 20 %
- Air changes (per hr): 13 - 14/hours
- Photoperiod (hrs dark / hrs light): 12/12 hours
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- other: refer to concentration section
- Concentration / amount:
Intradermal Induction Pre-test: 0.5, 1.0, 3.0 and 5.0 % in peanut oil
Epidermal Induction Pre-test; 1, 5, 10, 20, 30, 50, 80 % in vaseline and 100 % (undiluted)
Day 0 – Intradermal Induction Injections: 5.0 % in peanut oil
Day 8 – Epidermal Application Induction: 80 % in Vaseline
Day 21 – Epidermal Challenge: 1 % in Vaseline
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: refer to concentration section
- Concentration / amount:
Intradermal Induction Pre-test: 0.5, 1.0, 3.0 and 5.0 % in peanut oil
Epidermal Induction Pre-test; 1, 5, 10, 20, 30, 50, 80 % in vaseline and 100 % (undiluted)
Day 0 – Intradermal Induction Injections: 5.0 % in peanut oil
Day 8 – Epidermal Application Induction: 80 % in Vaseline
Day 21 – Epidermal Challenge: 1 % in Vaseline
- No. of animals per dose:
Number of animals per group
Intradermal Induction Pre-test 1 male, 1 female
Epidermal Induction Pre-test 2 male, 2 female
Control Group 10
Test Group 20- Details on study design:
Pre-tests to Determine Concentrations
Intradermal Induction Pre-test
Pre-treatment: A 5 cm wide area in the neck-shoulder region of 1 male and 1 female animal was shaved approximately 1 hour before
treatment.
Treatment: Two pairs of intradermal injections (0.1 ml) of FCA and one pair of injections for each concentration were administered, one of each on each side of the spine.
Observations: The test sites were examined 24and 48 hours after administration to determine the highest concentration to produce
mild to moderate irritation without systemic toxicity.
Epidermal Induction Pre-test
Pre-treatment: Two pairs of intradermal injections (0.1 ml) of a 1:1 mixture of FCA/physiological saline were administered to
2 male and 2 female animals
Treatment: Seven days later, the seven test article/vehicle mixtures and the undiluted test article were applied with Hill Top Chambers on four animals. Two animals were applied 30, 50, 80 and 100 % in four chambers, two on each flank
Two animals were applied 1, 5, 10 and 20 % in four chambers, two on each flank.
Observations: The test sites were examined 24and 48 hours after administration to determine the highest concentration to
cause mild to moderate irritation for the induction application and no irritation for the challenge application
(highest non-irritant dose).
Maximisation Test Procedure:
The Maximisation test was conducted with 10 animals in the vehicle control group and 20 animals in the test article group.
A set of intradermal induction injections was made on Day 0. A epidermal induction application was made once on day 8. The challenge epidermal application was once on Day 21.
Day 0
Pre-treatment: An area 5cm x 5cm on the neck was shaved approximately 1 hour before treatment.
Treatment: Three pairs of injections 0.1ml in volume were given in the shaved area so that one of each pair was on each side of the midline.
Vehicle control group injections: (1) adjuvant/physiological saline mixture, 1:1 v/v
(2) peanut oil
(3) peanut oil, 50% v/v with 1:1 adjuvant/physiological saline mixture
Test article group injections: (1) adjuvant/physiological saline mixture, 1:1 v/v
(2) test article in peanut oil
(3) test article in1:1 adjuvant/physiological saline mixture
Day 8
Treatment: A filter paper patch was fully loaded approximately 0.4 g) with the test article/vehicle mixture
(test article group) or Vaseline vehicle alone (vehicle control group) and held in place with the occlusive
dressing for 48 hours.
Day 21
Pre-treatment: The flanks of the animals were shaved immediately prior to treatment.
Treatment: One chamber loaded with the test article/vehicle mixture (approximately 0.35ml) was placed on one flank
(test flank) and one chamber loaded with the vehicle alone was placed on the other flank (vehicle flank) of the
animals of both groups. The chambers were held in place with the occlusive dressing for 24 hours.
Observations and Records
Period of observation: Through 48 hours after completion of the challenge application.
Scoring Interval: 24 and 48 hours after removal of the dressing for the challenge application.
Grading of skin reactions: Dermal reactions graded according to the Draize Scale.
Clinical Observations: Checked daily.
Mortality: Checked daily.
Body weight: Immediately before treatment and at test termination.- Positive control substance(s):
- yes
- Remarks:
- 2-Mercaptobenzothiazole
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- other: Sensitization
- Hours after challenge:
- 24
- Group:
- other: Control
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: other: Sensitization. . Hours after challenge: 24.0. Group: other: Control. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- other: Sensitization
- Hours after challenge:
- 24
- Group:
- test chemical
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: other: Sensitization. . Hours after challenge: 24.0. Group: test group. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- other: Sensitization
- Hours after challenge:
- 48
- Group:
- other: Control
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: other: Sensitization. . Hours after challenge: 48.0. Group: other: Control. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- other: Sensitiszation
- Hours after challenge:
- 48
- Group:
- test chemical
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: other: Sensitiszation. . Hours after challenge: 48.0. Group: test group. No with. + reactions: 0.0. Total no. in groups: 20.0.
Any other information on results incl. tables
Pre-tests, Intradermal Induction – The 5.0 % concentration was selected - For individual irritation scores refer to Table 1.
Pre-tests, Epidermal Application – The 80 % concentration was selected for epidermal induction. The 1.0 % concentration was selected for the epidermal challenge - For individual irritation scores refer to Table 2.
Skin Irritation Check – Positive skin irritation reactions were noted for all animals with the test article, there were no positive reactions among the vehicle control group. For individual results refer to Table 3.
Skin Reaction Following Challenge Application – There were no positive reactions at either the 24- or 48- hour readings for the test article or the vehicle control. Sensitization rate for the test article is therefore 0%. – Sensitization reactions are summarized in Table 4, for individual scores refer to Table 5 & 6.
There was no mortality in the study.
There were no remarkable clinical observations.
Body weights were no affected.
Applicant's summary and conclusion
- Interpretation of results:
- other: not required to be classified
- Remarks:
- Criteria used for interpretation of results: EU
- Conclusions:
According to the test results, CA 2455 A (Intermediate of CGA 276854) is not required to be classified for skin sensitization according to Commission Directive 93/21/EEC, issued May 4, 1993.- Executive summary:
A dermal sensitization test was conducted with CA 2455 A (Intermediate of CGA 276854) (batch LOT 3) using the Maximization procedure. Two groups of guinea pigs (10 vehicle control, 20 test) were included. On day 0, the test group animals were given a set of intradermal injections (including 5.0% CA 2455 A (Intermediate of CGA 276854) in peanut oil for the test group). The epidermal induction application was made on day 8; the vehicle control animals were treated with the vehicle alone, and the test animals with 80% CA 2455 A (Intermediate of CGA 276854) in vaseline. The epidermal challenge application on day 21 consisted of a paired application of the vehicle alone and 1% CA 2455 A (Intermediate of CGA 276854) in vaseline in both groups. Skin reactions on both the vehicle and test flanks were scored 24 and 48 hours after completion of the challenge application, according to the Draize scale.
There were no positive responses among either the vehicle control or test group animals on either the vehicle flank or the test flank; the sensitization rate for CA 2455 A (Intermediate of CGA 276854) was therefore 0 %. There was no mortality, and there were no remarkable clinical observations in any of the two groups. Body weights were not affected by treatment.
According to the test results, CA 2455 A (Intermediate of CGA 276854) is not required to be classified for skin sensitization according to Commission Directive 93/21/EEC, issued May 4, 1993.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.